,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Tumour lysis syndrome,1,16770807
1,22.0,Hyperuricaemia,1,16770807
2,22.0,Blood lactate dehydrogenase increased,2,16770807
3,22.0,Off label use,6,16770807
4,22.0,Blood creatinine increased,1,16770807
5,22.0,Hyperphosphataemia,1,16770807
6,22.0,Hypocalcaemia,1,16770807
0,22.0,Chromaturia,6,16770809
1,22.0,Fatigue,6,16770809
2,22.0,Jaundice cholestatic,3,16770809
3,22.0,Liver injury,6,16770809
4,22.0,Faeces pale,6,16770809
0,22.0,Erythema,1,16770812
1,22.0,Infusion related reaction,1,16770812
0,22.0,Intentional product use issue,6,16770833
1,22.0,White blood cell count decreased,6,16770833
2,22.0,Bone pain,1,16770833
3,22.0,Blood iron decreased,6,16770833
4,22.0,Fatigue,3,16770833
0,22.0,Chronic gastritis,3,16770839
0,22.0,Malaise,3,16770841
1,22.0,Weight decreased,3,16770841
2,22.0,Metastases to bone,3,16770841
0,22.0,Death,5,16770854
0,22.1,Oedema peripheral,1,16770951
1,22.1,Blood creatine phosphokinase increased,2,16770951
2,22.1,Face oedema,2,16770951
0,22.1,Nausea,6,16770972
1,22.1,Photosensitivity reaction,1,16770972
2,22.1,Pyrexia,6,16770972
3,22.1,Intertrigo,1,16770972
0,22.1,Cholangitis sclerosing,2,16770977
1,22.1,Hepatic function abnormal,2,16770977
0,22.1,Pneumonia,5,16770978
0,22.0,Metastases to lung,2,16770986
1,22.0,Cardio-respiratory arrest,5,16770986
2,22.0,Pneumonia,2,16770986
0,22.1,Dehydration,6,16771020
1,22.1,Platelet count decreased,1,16771020
2,22.1,Neutrophil count decreased,1,16771020
3,22.1,Renal tubular necrosis,1,16771020
4,22.1,Diarrhoea,1,16771020
0,22.0,Malignant neoplasm progression,1,16771058
0,22.1,Disease progression,5,16771067
1,22.1,Product use in unapproved indication,5,16771067
2,22.1,Therapy partial responder,6,16771067
3,22.1,Drug interaction,5,16771067
4,22.1,Malignant neoplasm progression,6,16771067
5,22.1,Death,5,16771067
6,22.1,Anaemia,5,16771067
7,22.1,Thrombocytopenia,5,16771067
8,22.1,Off label use,6,16771067
9,22.1,Chronic myeloid leukaemia,5,16771067
10,22.1,Breast cancer,6,16771067
11,22.1,Second primary malignancy,2,16771067
12,22.1,Polyneuropathy,5,16771067
0,22.0,Metastases to bone,6,16771110
1,22.0,Drug intolerance,6,16771110
2,22.0,Alopecia,3,16771110
3,22.0,Metastases to lung,6,16771110
4,22.0,Metastases to liver,6,16771110
0,22.0,Drug reaction with eosinophilia and systemic symptoms,2,16771178
0,22.1,Osteonecrosis of jaw,1,16771184
1,22.1,Jaw fracture,1,16771184
0,22.0,Malaise,6,16771191
1,22.0,Pain,6,16771191
2,22.0,Fatigue,6,16771191
3,22.0,Asthenia,6,16771191
0,22.0,Pain,6,16771228
1,22.0,Fatigue,6,16771228
2,22.0,Asthenia,6,16771228
0,22.0,Vomiting,1,16771231
1,22.0,Hypertensive crisis,1,16771231
2,22.0,Dyspnoea,1,16771231
3,22.0,Chest pain,1,16771231
0,22.1,Radiation pneumonitis,3,16771249
0,22.0,Erythema multiforme,3,16771250
0,22.1,Metastases to lymph nodes,6,16771251
1,22.1,Malignant neoplasm progression,5,16771251
2,22.1,Metastases to soft tissue,6,16771251
3,22.1,Metastases to pleura,6,16771251
4,22.1,Metastases to skin,6,16771251
5,22.1,Metastases to liver,6,16771251
0,22.0,White blood cell count decreased,3,16771255
1,22.0,Neutrophil count decreased,3,16771255
0,22.0,Cytomegalovirus infection,6,16771310
0,22.0,Pancreatitis acute,1,16771311
0,22.0,Product use in unapproved indication,6,16771341
1,22.0,Chromaturia,6,16771341
2,22.0,Product use complaint,6,16771341
0,22.0,Product use in unapproved indication,6,16771343
1,22.0,Fatigue,6,16771343
0,22.1,Adverse event,1,16771349
1,22.1,Malaise,6,16771349
2,22.1,Fatigue,1,16771349
3,22.1,Product use in unapproved indication,6,16771349
4,22.1,Retinopathy,1,16771349
0,22.1,Haematochezia,6,16771350
1,22.1,Thirst,6,16771350
2,22.1,Pain of skin,1,16771350
3,22.1,Fatigue,6,16771350
4,22.1,Product use in unapproved indication,6,16771350
5,22.1,Dry skin,6,16771350
6,22.1,Dysgeusia,6,16771350
7,22.1,Diarrhoea,6,16771350
8,22.1,Poor quality sleep,6,16771350
9,22.1,Vomiting,6,16771350
10,22.1,Adverse event,6,16771350
11,22.1,Decreased appetite,6,16771350
12,22.1,Rash,1,16771350
13,22.1,Acne,6,16771350
14,22.1,Constipation,6,16771350
0,22.1,Sepsis,1,16771352
1,22.1,Product use in unapproved indication,6,16771352
2,22.1,Diarrhoea,1,16771352
3,22.1,Fatigue,2,16771352
4,22.1,Dizziness,1,16771352
5,22.1,Disease progression,3,16771352
6,22.1,Hyponatraemia,2,16771352
0,22.0,Injury,6,16771361
1,22.0,Fall,6,16771361
0,22.1,Insomnia,6,16771389
1,22.1,Nausea,6,16771389
2,22.1,Abdominal discomfort,6,16771389
3,22.1,Fatigue,6,16771389
4,22.1,Gastric disorder,6,16771389
0,22.0,Autoimmune haemolytic anaemia,2,16771409
0,22.0,Off label use,,16771431
1,22.0,Traumatic fracture,6,16771431
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16771431
3,22.0,Gait disturbance,3,16771431
0,22.1,Pleural effusion,6,16771522
0,22.0,Death,5,16771539
0,22.1,Death,5,16771544
0,22.1,Infection,6,16771551
1,22.1,Vulvovaginal pruritus,6,16771551
0,22.0,Neoplasm progression,6,16771564
0,22.1,Neoplasm recurrence,3,16771571
0,22.0,Drug-induced liver injury,3,16771610
0,22.0,Erythema multiforme,1,16771680
1,22.0,Hepatic function abnormal,1,16771680
0,22.0,Blood pressure increased,6,16771786
1,22.0,Diarrhoea,6,16771786
0,22.1,Hernia repair,,16771806
0,22.0,Fatigue,3,16771818
1,22.0,Asthenia,3,16771818
2,22.0,Dyspnoea,6,16771818
3,22.0,Pneumonia,6,16771818
4,22.0,Nephrolithiasis,6,16771818
0,22.0,Malignant neoplasm progression,6,16771825
1,22.0,Drug resistance,6,16771825
0,22.0,Acute myeloid leukaemia,5,16771832
0,22.0,Flushing,1,16771834
1,22.0,Dyspnoea,1,16771834
2,22.0,Erythema,1,16771834
0,22.0,Arteriovenous graft site stenosis,1,16771854
0,22.0,Lichenoid keratosis,1,16771865
1,22.0,Oedema peripheral,1,16771865
0,22.1,Encephalopathy,3,16771869
0,22.1,Death,5,16771870
1,22.1,Hospitalisation,6,16771870
2,22.1,Off label use,6,16771870
0,22.0,Pancytopenia,3,16771875
0,22.0,Colorectal cancer,3,16771879
0,22.1,Brain tumour operation,,16771911
1,22.1,Brain cancer metastatic,,16771911
0,22.0,Death,5,16771936
0,22.0,Proctitis,1,16771992
0,22.0,Hypertension,6,16772002
0,22.0,Cardiomyopathy,2,16772036
0,22.1,Colorectal cancer,3,16772071
1,22.1,Malaise,2,16772071
0,22.1,Hepatic function abnormal,3,16772072
0,22.0,Skin disorder,6,16772078
1,22.0,Toxic epidermal necrolysis,6,16772078
2,22.0,Irritable bowel syndrome,6,16772078
3,22.0,Malignant neoplasm progression,6,16772078
0,22.0,Second primary malignancy,3,16772080
1,22.0,Asthenia,6,16772080
2,22.0,Brain neoplasm,3,16772080
3,22.0,Neoplasm progression,6,16772080
4,22.0,Nausea,6,16772080
0,22.1,Colorectal cancer,6,16772083
1,22.1,Second primary malignancy,6,16772083
2,22.1,Anaemia,6,16772083
3,22.1,Neoplasm progression,6,16772083
0,22.0,Pain in extremity,6,16772085
1,22.0,Arthralgia,6,16772085
2,22.0,Neuropathy peripheral,6,16772085
0,22.1,Vision blurred,3,16772091
1,22.1,Neutropenia,3,16772091
2,22.1,Fatigue,3,16772091
3,22.1,Hypertension,3,16772091
4,22.1,Abdominal pain,3,16772091
5,22.1,Anaemia,3,16772091
6,22.1,Malaise,3,16772091
7,22.1,Thrombocytopenia,3,16772091
8,22.1,Visual impairment,3,16772091
0,22.1,Therapy cessation,,16772143
1,22.1,Hepatectomy,,16772143
0,22.1,Rash erythematous,,16772183
0,22.1,Death,,16772215
0,22.1,Pain,,16772255
1,22.1,Musculoskeletal stiffness,,16772255
0,22.0,Hypersensitivity,1,16772309
0,22.1,Muscle spasms,,16772354
1,22.1,Chest discomfort,,16772354
0,22.0,Hypokalaemia,1,16772487
1,22.0,Neutropenia,1,16772487
2,22.0,Nausea,1,16772487
3,22.0,Diarrhoea,1,16772487
4,22.0,Febrile infection,6,16772487
5,22.0,Anaemia,1,16772487
6,22.0,Fatigue,1,16772487
0,22.1,Hospitalisation,,16772540
0,22.1,Disease progression,,16772554
0,22.1,Disease progression,,16772558
0,22.1,Disease progression,,16772563
0,22.0,Metastases to pharynx,5,16772583
1,22.0,Malignant neoplasm progression,5,16772583
2,22.0,Blood glucose fluctuation,3,16772583
3,22.0,Hypophagia,5,16772583
4,22.0,General physical health deterioration,5,16772583
5,22.0,Cough,5,16772583
6,22.0,Fluid intake reduced,5,16772583
7,22.0,Metastasis,5,16772583
8,22.0,Metastases to spine,5,16772583
9,22.0,Pulmonary oedema,3,16772583
0,22.0,General physical health deterioration,1,16772592
1,22.0,Renal failure,1,16772592
2,22.0,Diarrhoea,1,16772592
0,22.0,Neutrophil count decreased,6,16772650
1,22.0,Electrocardiogram QT prolonged,6,16772650
0,22.0,Second primary malignancy,6,16772654
1,22.0,Lung neoplasm malignant,6,16772654
2,22.0,Thrombocytopenia,6,16772654
0,22.0,White blood cell count decreased,1,16772662
1,22.0,Neutropenia,1,16772662
0,22.0,Gastrointestinal haemorrhage,1,16772669
1,22.0,Febrile neutropenia,5,16772669
2,22.0,Decreased appetite,5,16772669
3,22.0,Pneumonia,5,16772669
4,22.0,Respiratory failure,5,16772669
5,22.0,General physical health deterioration,6,16772669
6,22.0,Bone marrow failure,1,16772669
0,22.0,Malignant neoplasm progression,6,16772684
1,22.0,Pneumonitis,2,16772684
0,22.0,Hidradenitis,2,16772705
0,22.0,Lymphangioleiomyomatosis,2,16772717
1,22.0,Respiratory failure,2,16772717
2,22.0,Condition aggravated,2,16772717
0,22.1,Diarrhoea,,16772718
1,22.1,Constipation,,16772718
2,22.1,Nausea,,16772718
3,22.1,Vomiting,,16772718
4,22.1,Abdominal pain,,16772718
0,22.0,Malaise,6,16772739
0,22.1,Somnolence,6,16772752
1,22.1,Musculoskeletal chest pain,3,16772752
2,22.1,Asthenia,6,16772752
3,22.1,Weight decreased,6,16772752
4,22.1,Fatigue,3,16772752
5,22.1,White blood cell count decreased,6,16772752
6,22.1,Cough,3,16772752
0,22.0,Sepsis,6,16772773
1,22.0,Diarrhoea,6,16772773
2,22.0,Acute kidney injury,2,16772773
0,22.1,Drug interaction,6,16772837
1,22.1,Somnolence,6,16772837
2,22.1,Bronchitis,6,16772837
3,22.1,Prostatic specific antigen increased,6,16772837
4,22.1,Hypoacusis,3,16772837
5,22.1,Fatigue,6,16772837
6,22.1,Sinusitis,6,16772837
7,22.1,Macular degeneration,3,16772837
0,22.0,Immediate post-injection reaction,1,16772860
1,22.0,Chest discomfort,1,16772860
2,22.0,Oxygen saturation abnormal,1,16772860
3,22.0,Flushing,1,16772860
4,22.0,Vomiting,1,16772860
0,22.0,Arthralgia,2,16772864
1,22.0,Bone pain,2,16772864
2,22.0,Myalgia,2,16772864
0,22.0,Condition aggravated,3,16772878
0,22.0,Wheezing,6,16772891
1,22.0,Erythema,6,16772891
2,22.0,Chest pain,6,16772891
3,22.0,Pruritus,6,16772891
4,22.0,Throat irritation,6,16772891
5,22.0,Back pain,6,16772891
6,22.0,Cough,6,16772891
7,22.0,Dyspnoea,6,16772891
8,22.0,Hypertension,6,16772891
0,22.0,Emotional distress,3,16773012
1,22.0,Cyanosis,3,16773012
2,22.0,Nausea,3,16773012
3,22.0,Erythema,3,16773012
4,22.0,Alcohol intolerance,3,16773012
5,22.0,Discomfort,3,16773012
6,22.0,Depressed level of consciousness,6,16773012
7,22.0,Headache,3,16773012
0,22.1,Hepatic function abnormal,2,16773026
1,22.1,Radiation pneumonitis,3,16773026
0,22.1,Encephalitis autoimmune,2,16773027
0,22.0,Weight decreased,1,16773028
1,22.0,Diarrhoea,1,16773028
2,22.0,Cough,6,16773028
3,22.0,Gastritis,1,16773028
4,22.0,Malignant neoplasm progression,6,16773028
5,22.0,Nausea,6,16773028
6,22.0,Paronychia,1,16773028
7,22.0,Throat irritation,6,16773028
8,22.0,Stomatitis,1,16773028
0,22.0,Malignant neoplasm progression,5,16773058
0,22.0,Liver injury,5,16773061
0,22.0,Gastrointestinal haemorrhage,1,16773072
1,22.0,Pneumonia,5,16773072
2,22.0,Urinary tract infection,1,16773072
3,22.0,Septic shock,1,16773072
0,22.0,Oxygen saturation decreased,6,16773104
1,22.0,Dyspnoea,6,16773104
2,22.0,Hypotension,6,16773104
3,22.0,Hyperhidrosis,6,16773104
4,22.0,Flushing,6,16773104
0,22.1,Body temperature increased,1,16773111
1,22.1,Pain,1,16773111
2,22.1,Tremor,1,16773111
3,22.1,Chills,1,16773111
4,22.1,Feeling abnormal,1,16773111
5,22.1,Uveitis,1,16773111
0,22.0,Second primary malignancy,1,16773126
1,22.0,Myelodysplastic syndrome,1,16773126
0,22.1,Optic neuritis,4,16773186
1,22.1,Iridocyclitis,1,16773186
2,22.1,Sepsis,1,16773186
0,22.0,Hypertension,3,16773192
1,22.0,Arthralgia,3,16773192
2,22.0,Malaise,6,16773192
3,22.0,Rash,6,16773192
4,22.0,Palmar-plantar erythrodysaesthesia syndrome,3,16773192
5,22.0,Back pain,3,16773192
6,22.0,Anaemia,3,16773192
7,22.0,Neutropenia,3,16773192
8,22.0,Fatigue,3,16773192
9,22.0,Oedema peripheral,3,16773192
10,22.0,Thrombocytopenia,3,16773192
0,22.0,Stress,1,16773197
1,22.0,Hypoxia,1,16773197
2,22.0,Off label use,1,16773197
3,22.0,Drug hypersensitivity,1,16773197
4,22.0,Headache,1,16773197
0,22.0,Cervix carcinoma,2,16773203
0,22.0,Malignant neoplasm progression,6,16773204
1,22.0,Breast cancer,6,16773204
0,22.0,Deafness,6,16773205
0,22.0,Malignant neoplasm progression,3,16773207
1,22.0,Breast cancer metastatic,3,16773207
2,22.0,Drug intolerance,3,16773207
0,22.0,Rash,2,16773223
1,22.0,Pyrexia,6,16773223
2,22.0,Joint swelling,2,16773223
3,22.0,Neutropenia,6,16773223
4,22.0,Thrombocytopenia,6,16773223
5,22.0,Ear swelling,6,16773223
6,22.0,Immune-mediated adverse reaction,6,16773223
7,22.0,Off label use,6,16773223
0,22.0,Dry skin,3,16773236
1,22.0,Hyperhidrosis,3,16773236
2,22.0,Nausea,3,16773236
3,22.0,Pain in extremity,3,16773236
4,22.0,Sinus tachycardia,3,16773236
5,22.0,Arthralgia,3,16773236
6,22.0,Pollakiuria,3,16773236
7,22.0,Mass,3,16773236
8,22.0,Myalgia,3,16773236
9,22.0,Pyrexia,3,16773236
10,22.0,Sepsis,3,16773236
11,22.0,Urinary tract infection,3,16773236
12,22.0,Abdominal pain upper,3,16773236
13,22.0,Accidental overdose,3,16773236
14,22.0,Bone pain,3,16773236
15,22.0,Joint swelling,3,16773236
16,22.0,Peripheral swelling,3,16773236
17,22.0,Urine odour abnormal,3,16773236
18,22.0,Decreased appetite,3,16773236
19,22.0,Dysuria,3,16773236
20,22.0,Contusion,3,16773236
21,22.0,Dysgeusia,3,16773236
22,22.0,Hepatic steatosis,3,16773236
23,22.0,Leukocytosis,3,16773236
0,22.0,Flushing,1,16773237
1,22.0,Oxygen saturation decreased,1,16773237
2,22.0,Vomiting,1,16773237
3,22.0,Chest discomfort,1,16773237
0,22.0,Pneumonitis,6,16773238
1,22.0,Lymphadenopathy mediastinal,6,16773238
2,22.0,Splenomegaly,6,16773238
0,22.1,Blood sodium decreased,6,16773241
1,22.1,Headache,2,16773241
2,22.1,Asthenia,6,16773241
3,22.1,Spinal compression fracture,2,16773241
4,22.1,Stress,6,16773241
5,22.1,Bone loss,6,16773241
6,22.1,Pain,3,16773241
7,22.1,Myocardial infarction,2,16773241
8,22.1,Blood pressure decreased,6,16773241
9,22.1,Osteoporosis,6,16773241
10,22.1,Therapeutic product effect incomplete,2,16773241
0,22.1,Hepatitis B,6,16773314
0,22.0,Drug abuse,6,16773336
0,22.1,Clostridium difficile colitis,,16773351
0,22.1,Hospitalisation,,16773355
0,22.1,Back pain,,16773363
1,22.1,Chest pain,,16773363
2,22.1,Infusion related reaction,,16773363
3,22.1,Headache,,16773363
0,22.1,Fatigue,,16773369
1,22.1,Hypophagia,,16773369
2,22.1,Asthenia,,16773369
0,22.1,Hospitalisation,,16773441
0,22.1,Hospitalisation,,16773447
0,22.1,Hypertension,,16773451
0,22.1,Disease progression,,16773459
0,22.0,Hyperkalaemia,3,16773473
1,22.0,Proteinuria,3,16773473
2,22.0,Hypoproteinaemia,3,16773473
3,22.0,Microangiopathic haemolytic anaemia,3,16773473
4,22.0,Vomiting,3,16773473
5,22.0,Chronic kidney disease,3,16773473
6,22.0,Thrombocytopenia,3,16773473
0,22.1,Hypovitaminosis,,16773486
1,22.1,Blood electrolytes increased,,16773486
2,22.1,Asthenia,,16773486
3,22.1,Vomiting,,16773486
0,22.0,Diplopia,3,16773511
1,22.0,Palatal disorder,3,16773511
2,22.0,Unevaluable event,3,16773511
3,22.0,Muscular weakness,3,16773511
4,22.0,Dysstasia,3,16773511
5,22.0,Muscle atrophy,3,16773511
6,22.0,Dysphagia,3,16773511
7,22.0,Adverse event,3,16773511
8,22.0,Speech disorder,3,16773511
0,22.1,Disease progression,,16773514
0,22.1,Death,,16773543
0,22.0,Cerebral circulatory failure,6,16773547
1,22.0,Pyrexia,6,16773547
2,22.0,Abdominal pain upper,6,16773547
3,22.0,Hepatic function abnormal,1,16773547
4,22.0,Nasal congestion,6,16773547
5,22.0,Cough,6,16773547
6,22.0,Hair colour changes,2,16773547
7,22.0,Insomnia,6,16773547
8,22.0,Hypertension,6,16773547
0,22.1,Seizure,,16773556
0,22.0,Hepatic encephalopathy,6,16773585
0,22.0,Rhinitis,1,16773608
1,22.0,Metastases to lung,3,16773608
2,22.0,Neutropenia,1,16773608
3,22.0,Skin reaction,1,16773608
4,22.0,Mucosal inflammation,6,16773608
5,22.0,Fatigue,6,16773608
6,22.0,Nervous system disorder,6,16773608
7,22.0,Cough,1,16773608
8,22.0,Alopecia,6,16773608
9,22.0,Dyspnoea,6,16773608
10,22.0,Mucosal inflammation,6,16773608
11,22.0,Conjunctivitis,1,16773608
0,22.0,Insomnia,3,16773614
1,22.0,Hypotension,3,16773614
2,22.0,Muscle spasms,3,16773614
0,22.0,Death,5,16773633
0,22.0,Dysarthria,6,16773634
1,22.0,Ammonia increased,6,16773634
0,22.0,Malignant neoplasm progression,5,16773635
0,22.0,Death,5,16773637
1,22.0,Dysgeusia,6,16773637
0,22.1,Malaise,,16773694
0,22.1,Death,,16773695
0,22.0,Myelodysplastic syndrome,1,16773720
1,22.0,Bronchopulmonary aspergillosis,6,16773720
2,22.0,Anaemia,6,16773720
3,22.0,Thrombocytopenia,6,16773720
4,22.0,Graft versus host disease,6,16773720
5,22.0,Cytomegalovirus infection,6,16773720
6,22.0,Granulocytopenia,6,16773720
7,22.0,Second primary malignancy,1,16773720
0,22.0,Anaemia,5,16773757
1,22.0,General physical health deterioration,5,16773757
0,22.0,Ischaemic stroke,2,16773855
0,22.0,Neutropenia,1,16773908
1,22.0,Bone marrow failure,1,16773908
2,22.0,Leukopenia,1,16773908
0,22.0,Nausea,6,16773920
1,22.0,Pyrexia,4,16773920
0,22.0,Hypoaesthesia,2,16773940
1,22.0,White blood cell count decreased,6,16773940
2,22.0,Neutrophil count decreased,6,16773940
3,22.0,Paraesthesia,2,16773940
4,22.0,Peripheral swelling,2,16773940
5,22.0,Feeling hot,2,16773940
0,22.0,Malignant neoplasm progression,6,16773947
1,22.0,Drug ineffective,6,16773947
0,22.0,Death,5,16774137
0,22.0,Chest pain,1,16774174
1,22.0,Hypertensive crisis,1,16774174
2,22.0,Vomiting,1,16774174
3,22.0,Dyspnoea,1,16774174
0,22.0,Cerebral infarction,6,16774228
0,22.0,Defaecation disorder,6,16774232
1,22.0,Platelet count decreased,6,16774232
2,22.0,Decreased appetite,6,16774232
3,22.0,Mouth haemorrhage,6,16774232
4,22.0,Death,5,16774232
5,22.0,Proctalgia,6,16774232
6,22.0,Pain,6,16774232
7,22.0,Coma,6,16774232
0,22.0,Bone marrow toxicity,1,16774287
0,22.0,Rash,3,16774331
0,22.0,Functional gastrointestinal disorder,6,16774347
1,22.0,Renal impairment,3,16774347
2,22.0,Diarrhoea,3,16774347
0,22.0,Tooth infection,6,16774419
1,22.0,Toothache,6,16774419
0,22.1,Dysphagia,6,16774432
1,22.1,Hernia,6,16774432
0,22.0,Off label use,6,16774470
1,22.0,Diarrhoea,1,16774470
2,22.0,Intentional product use issue,6,16774470
3,22.0,Dehydration,1,16774470
0,22.0,Hyperammonaemia,1,16774491
1,22.0,Encephalopathy,1,16774491
2,22.0,Status epilepticus,1,16774491
0,22.0,Neutropenia,6,16774512
1,22.0,Inappropriate schedule of product administration,6,16774512
0,22.0,Atrial flutter,6,16774554
1,22.0,Blood blister,2,16774554
2,22.0,Heart rate irregular,6,16774554
3,22.0,Blood urine present,2,16774554
4,22.0,Blood pressure increased,6,16774554
5,22.0,Thyroid disorder,6,16774554
6,22.0,Arrhythmia,6,16774554
7,22.0,Thrombocytopenia,3,16774554
0,22.0,Pancreatitis acute,1,16774587
0,22.1,Death,5,16774621
0,22.0,Tinnitus,3,16774656
1,22.0,Fatigue,3,16774656
2,22.0,Nausea,3,16774656
0,22.0,Death,5,16774661
0,22.0,Respiratory failure,5,16774692
1,22.0,Neoplasm,5,16774692
0,22.0,Muscle strain,6,16774709
1,22.0,Peripheral swelling,2,16774709
2,22.0,Deafness,3,16774709
3,22.0,Metastases to liver,6,16774709
4,22.0,Metastases to spleen,6,16774709
5,22.0,Pneumonia,1,16774709
0,22.0,Constipation,3,16774730
1,22.0,Fatigue,6,16774730
2,22.0,Drug ineffective,6,16774730
3,22.0,Pain in extremity,2,16774730
0,22.0,Mobility decreased,3,16774806
1,22.0,Angiopathy,3,16774806
2,22.0,Pain in extremity,3,16774806
3,22.0,Diabetic ulcer,3,16774806
4,22.0,Blood pressure diastolic decreased,3,16774806
5,22.0,Myocardial infarction,3,16774806
6,22.0,Gait disturbance,3,16774806
7,22.0,Poor peripheral circulation,3,16774806
8,22.0,Infection,3,16774806
0,22.1,Lower gastrointestinal perforation,6,16774864
0,22.0,Pancytopenia,5,16774956
1,22.0,Anaemia,5,16774956
2,22.0,Hypercalcaemia,5,16774956
3,22.0,Hormone-refractory prostate cancer,5,16774956
0,22.0,Optic ischaemic neuropathy,3,16774962
0,22.0,Lower respiratory tract infection,1,16774977
0,22.0,Lichenoid keratosis,6,16774978
1,22.0,Photosensitivity reaction,6,16774978
0,22.0,Leukopenia,1,16774996
1,22.0,Thrombocytopenia,1,16774996
2,22.0,Anaemia,3,16774996
3,22.0,Septic shock,1,16774996
0,22.0,Rash maculo-papular,2,16774997
1,22.0,Hepatocellular injury,3,16774997
0,22.1,Withdrawal of life support,5,16775014
1,22.1,Terminal state,5,16775014
2,22.1,Coma,6,16775014
3,22.1,Ascites,3,16775014
4,22.1,Vomiting,6,16775014
5,22.1,Off label use,3,16775014
6,22.1,Nausea,6,16775014
0,22.1,Stillbirth,5,16775042
1,22.1,Foetal exposure during pregnancy,5,16775042
2,22.1,Foetal death,5,16775042
3,22.1,Neonatal asphyxia,5,16775042
0,22.1,Stomatitis,6,16775059
1,22.1,Rhinorrhoea,3,16775059
2,22.1,Sinusitis,3,16775059
3,22.1,Dyspnoea exertional,3,16775059
4,22.1,Erythema,3,16775059
5,22.1,Immune system disorder,3,16775059
6,22.1,Dyspnoea,3,16775059
7,22.1,Lung disorder,3,16775059
8,22.1,Taste disorder,3,16775059
9,22.1,Aphonia,3,16775059
10,22.1,Headache,6,16775059
11,22.1,Nasopharyngitis,3,16775059
12,22.1,Malaise,3,16775059
13,22.1,Tooth fracture,1,16775059
14,22.1,Cough,6,16775059
15,22.1,Muscle spasms,3,16775059
16,22.1,Throat irritation,3,16775059
17,22.1,Gastric disorder,1,16775059
18,22.1,Eye irritation,6,16775059
19,22.1,Lower respiratory tract infection,6,16775059
20,22.1,Oropharyngeal pain,3,16775059
21,22.1,Asthenia,6,16775059
22,22.1,Chest pain,3,16775059
23,22.1,Angular cheilitis,3,16775059
24,22.1,Throat irritation,3,16775059
25,22.1,Gastric disorder,1,16775059
26,22.1,Sinus disorder,3,16775059
27,22.1,Diarrhoea,1,16775059
28,22.1,Breath sounds abnormal,6,16775059
29,22.1,Rash macular,3,16775059
30,22.1,Epistaxis,3,16775059
0,22.0,Chest pain,1,16775097
1,22.0,Dyspnoea at rest,1,16775097
2,22.0,Hyperhidrosis,1,16775097
3,22.0,Vomiting,1,16775097
4,22.0,Feeling hot,1,16775097
0,22.0,Pulmonary embolism,5,16775133
0,22.0,Hypertriglyceridaemia,1,16775148
0,22.0,Angiopathy,6,16775176
1,22.0,Seizure,6,16775176
0,22.0,Dyspnoea,6,16775185
1,22.0,Haemoptysis,3,16775185
2,22.0,Cough,3,16775185
3,22.0,Malignant neoplasm progression,3,16775185
0,22.1,Hypotension,1,16775241
1,22.1,Fatigue,6,16775241
2,22.1,Urinary retention,6,16775241
3,22.1,Ureteral stent insertion,6,16775241
4,22.1,Dry mouth,6,16775241
5,22.1,Headache,2,16775241
6,22.1,Micturition urgency,6,16775241
7,22.1,Constipation,3,16775241
8,22.1,Neck pain,6,16775241
9,22.1,Vomiting,6,16775241
10,22.1,Product dose omission,6,16775241
11,22.1,Adverse drug reaction,6,16775241
12,22.1,Fall,6,16775241
13,22.1,Low density lipoprotein increased,6,16775241
14,22.1,Back pain,3,16775241
15,22.1,Taste disorder,6,16775241
16,22.1,Blood uric acid increased,6,16775241
17,22.1,Diarrhoea,3,16775241
0,22.0,Hypokalaemia,6,16775264
1,22.0,Chest pain,6,16775264
2,22.0,Electrocardiogram QT prolonged,6,16775264
3,22.0,Altered state of consciousness,6,16775264
0,22.0,Physical deconditioning,6,16775302
0,22.0,Nausea,6,16775330
1,22.0,Vomiting,6,16775330
2,22.0,Diabetic ketoacidosis,1,16775330
3,22.0,Asthenia,2,16775330
0,22.0,Death,5,16775344
0,22.0,Dehydration,2,16775394
1,22.0,Nervous system disorder,3,16775394
0,22.0,Blood albumin decreased,3,16775399
1,22.0,Hypoproteinaemia,3,16775399
0,22.0,Drug resistance,6,16775408
1,22.0,Malignant neoplasm progression,6,16775408
0,22.0,Pneumonia,5,16775444
1,22.0,Neutropenia,5,16775444
0,22.0,Dermatomyositis,6,16775458
0,22.0,Malignant neoplasm progression,6,16775463
1,22.0,Drug resistance,6,16775463
0,22.0,Lung infection,1,16775486
1,22.0,Arthritis,6,16775486
2,22.0,Pyrexia,1,16775486
3,22.0,Upper respiratory tract infection,6,16775486
4,22.0,Nausea,6,16775486
5,22.0,Pneumonitis,1,16775486
6,22.0,Lymphopenia,6,16775486
7,22.0,Peripheral sensory neuropathy,2,16775486
8,22.0,Neutropenia,6,16775486
9,22.0,Dizziness,1,16775486
10,22.0,Myalgia,6,16775486
0,22.0,Death,5,16775524
0,22.0,Skin disorder,3,16775528
1,22.0,Hepatic function abnormal,3,16775528
0,22.0,Malignant neoplasm progression,6,16775529
1,22.0,Drug resistance,6,16775529
0,22.1,Takayasu^s arteritis,1,16775538
1,22.1,Chemotherapy,6,16775538
0,22.0,Hypertension,1,16775547
1,22.0,Diarrhoea,3,16775547
2,22.0,Neutropenia,2,16775547
3,22.0,Prehypertension,3,16775547
4,22.0,Cough,3,16775547
5,22.0,Rash,3,16775547
6,22.0,Anaemia,3,16775547
7,22.0,Thrombocytopenia,3,16775547
0,22.0,Death,5,16775554
0,22.0,Off label use,6,16775570
1,22.0,Osteonecrosis of jaw,3,16775570
2,22.0,Implant site pain,3,16775570
0,22.0,Ascites,6,16775610
1,22.0,Full blood count decreased,2,16775610
2,22.0,Neoplasm progression,6,16775610
0,22.1,Interstitial lung disease,2,16775635
0,22.0,Malignant neoplasm progression,6,16775636
1,22.0,White blood cell count decreased,6,16775636
2,22.0,Fatigue,6,16775636
0,22.0,Neuropathy peripheral,3,16775653
1,22.0,Type IV hypersensitivity reaction,3,16775653
2,22.0,Paraesthesia,3,16775653
0,22.1,Decreased appetite,3,16775659
1,22.1,Ascites,6,16775659
2,22.1,Malignant neoplasm progression,6,16775659
0,22.1,Malignant neoplasm progression,5,16775663
1,22.1,Ascites,6,16775663
0,22.1,Death,,16775668
0,22.0,Haematotoxicity,6,16775687
0,22.1,Vomiting,6,16775726
1,22.1,Liver disorder,6,16775726
2,22.1,Muscle spasms,3,16775726
3,22.1,Dry skin,3,16775726
4,22.1,Bone disorder,2,16775726
5,22.1,Nausea,3,16775726
6,22.1,Oral pain,3,16775726
7,22.1,Skin exfoliation,3,16775726
8,22.1,Blister,3,16775726
9,22.1,Weight decreased,3,16775726
10,22.1,Abdominal discomfort,3,16775726
0,22.0,Surgery,6,16775735
0,22.1,Intestinal obstruction,1,16775742
1,22.1,Lung opacity,1,16775742
0,22.0,Nephropathy,6,16775777
0,22.0,Left ventricular dysfunction,3,16775783
0,22.0,Sjogren^s syndrome,6,16775784
1,22.0,Vasculitic rash,6,16775784
2,22.0,Dry eye,2,16775784
0,22.1,Prostatic specific antigen increased,6,16775793
0,22.1,Diabetes mellitus,6,16775795
1,22.1,Enterocolitis,1,16775795
0,22.0,Altered state of consciousness,1,16775796
1,22.0,Small intestinal perforation,1,16775796
2,22.0,Ascites,6,16775796
0,22.0,Toxic epidermal necrolysis,5,16775797
1,22.0,Scab,5,16775797
2,22.0,Cheilitis,5,16775797
3,22.0,Rash,5,16775797
4,22.0,Staphylococcal infection,5,16775797
5,22.0,Off label use,6,16775797
6,22.0,Epidermolysis,5,16775797
0,22.0,Pneumonia,6,16775838
1,22.0,Atelectasis,6,16775838
2,22.0,Renal cyst,6,16775838
3,22.0,Mean platelet volume increased,6,16775838
4,22.0,Mean cell haemoglobin concentration decreased,6,16775838
5,22.0,Monocyte percentage increased,6,16775838
6,22.0,Blood glucose decreased,6,16775838
7,22.0,Blood creatinine increased,6,16775838
8,22.0,Hypoxia,6,16775838
9,22.0,Granuloma,6,16775838
10,22.0,Protein total decreased,6,16775838
11,22.0,Dyspnoea,6,16775838
12,22.0,Respiratory failure,6,16775838
13,22.0,Dyspnoea exertional,6,16775838
14,22.0,Blood urea decreased,6,16775838
15,22.0,Pleural effusion,2,16775838
16,22.0,Aortic stenosis,6,16775838
17,22.0,Aortic valve stenosis,6,16775838
18,22.0,Monocyte count increased,6,16775838
19,22.0,Platelet count decreased,6,16775838
20,22.0,Activated partial thromboplastin time prolonged,6,16775838
21,22.0,Pericardial effusion,6,16775838
0,22.1,Cognitive disorder,3,16775843
1,22.1,Confusional state,3,16775843
0,22.0,White blood cell count decreased,6,16775864
0,22.0,Cerebrovascular accident,6,16775933
1,22.0,Blood pressure increased,6,16775933
0,22.0,Diarrhoea,1,16775938
1,22.0,Pyrexia,1,16775938
2,22.0,Abdominal symptom,1,16775938
3,22.0,Decreased appetite,1,16775938
4,22.0,Pancytopenia,1,16775938
0,22.1,Pulmonary oedema,1,16775948
1,22.1,Neoplasm progression,2,16775948
0,22.1,Herpes zoster,1,16775965
0,22.0,Dry mouth,6,16775968
1,22.0,Pyrexia,6,16775968
2,22.0,Pain,6,16775968
3,22.0,Pollakiuria,6,16775968
4,22.0,Sensory disturbance,6,16775968
0,22.1,Dyspnoea,6,16775973
0,22.0,Neoplasm progression,6,16775974
0,22.1,Abdominal pain upper,3,16775992
1,22.1,Ageusia,6,16775992
2,22.1,Constipation,3,16775992
3,22.1,Arthralgia,3,16775992
4,22.1,Bone pain,3,16775992
5,22.1,Skin lesion,3,16775992
6,22.1,Glossodynia,6,16775992
7,22.1,Urticaria,6,16775992
8,22.1,Dysphonia,6,16775992
9,22.1,Infection,6,16775992
10,22.1,Pain,3,16775992
11,22.1,Headache,6,16775992
12,22.1,Snoring,3,16775992
13,22.1,Fatigue,6,16775992
0,22.0,Renal impairment,3,16776020
1,22.0,Femur fracture,1,16776020
0,22.1,Drug ineffective,6,16776030
0,22.0,Rash maculo-papular,1,16776038
1,22.0,Eruptive pseudoangiomatosis,1,16776038
0,22.0,Oral mucosa erosion,6,16776039
1,22.0,Decreased appetite,2,16776039
2,22.0,Cerebrovascular insufficiency,6,16776039
0,22.0,Leukopenia,2,16776076
0,22.0,Weight decreased,1,16776126
1,22.0,Depression,1,16776126
2,22.0,Diarrhoea,1,16776126
0,22.0,Rash maculo-papular,2,16776177
1,22.0,Hepatocellular injury,3,16776177
0,22.0,Deep vein thrombosis,1,16776225
1,22.0,Metastases to lymph nodes,6,16776225
2,22.0,Product use issue,6,16776225
3,22.0,Off label use,6,16776225
0,22.0,Metastases to lymph nodes,6,16776226
1,22.0,Malignant neoplasm progression,6,16776226
2,22.0,Metastases to abdominal cavity,6,16776226
0,22.1,Nausea,6,16776234
1,22.1,Malignant neoplasm progression,6,16776234
2,22.1,Decreased appetite,6,16776234
3,22.1,White blood cell count decreased,6,16776234
0,22.0,Alopecia,3,16776267
0,22.1,Alopecia,6,16776277
1,22.1,Stomatitis,6,16776277
0,22.1,Scar,6,16776312
1,22.1,Depressed mood,6,16776312
2,22.1,Irritability,3,16776312
3,22.1,Waist circumference increased,6,16776312
4,22.1,Fatigue,6,16776312
5,22.1,Lung neoplasm malignant,6,16776312
6,22.1,Weight increased,6,16776312
7,22.1,Pain,6,16776312
8,22.1,Heart rate increased,6,16776312
9,22.1,Burning sensation,6,16776312
10,22.1,Fatigue,3,16776312
11,22.1,Rib fracture,6,16776312
12,22.1,Back pain,6,16776312
13,22.1,Feeling hot,3,16776312
14,22.1,Somnolence,6,16776312
0,22.0,Vomiting,6,16776343
1,22.0,Proteinuria,6,16776343
2,22.0,White blood cell count decreased,6,16776343
3,22.0,Nausea,6,16776343
4,22.0,Platelet count decreased,6,16776343
5,22.0,Haemorrhage,6,16776343
6,22.0,Hypertension,6,16776343
7,22.0,Haemoglobin decreased,6,16776343
8,22.0,Hepatic function abnormal,6,16776343
0,22.0,Anaemia,3,16776362
1,22.0,Vomiting,2,16776362
2,22.0,Intestinal obstruction,2,16776362
3,22.0,Nausea,2,16776362
0,22.1,Swelling,1,16776377
1,22.1,Fistula,1,16776377
2,22.1,Exposed bone in jaw,1,16776377
3,22.1,Gingival pain,1,16776377
4,22.1,Osteonecrosis of jaw,1,16776377
5,22.1,Purulence,1,16776377
6,22.1,Periodontal disease,2,16776377
7,22.1,Loose tooth,1,16776377
8,22.1,Pain,1,16776377
0,22.1,Autoimmune hepatitis,2,16776398
1,22.1,Alanine aminotransferase increased,2,16776398
2,22.1,Malignant neoplasm progression,5,16776398
3,22.1,Aspartate aminotransferase increased,2,16776398
4,22.1,Hepatic failure,6,16776398
0,22.0,Malaise,6,16776399
0,22.1,Fall,6,16776432
1,22.1,Death,5,16776432
2,22.1,Asthenia,6,16776432
3,22.1,Hyperhidrosis,3,16776432
4,22.1,Hypotension,1,16776432
5,22.1,Hospitalisation,6,16776432
6,22.1,Pollakiuria,6,16776432
7,22.1,Vision blurred,6,16776432
8,22.1,Platelet count decreased,3,16776432
9,22.1,Petechiae,6,16776432
10,22.1,Neuropathy peripheral,6,16776432
11,22.1,Unevaluable event,6,16776432
12,22.1,White blood cell count decreased,6,16776432
13,22.1,Carbohydrate antigen 125 increased,3,16776432
14,22.1,Contusion,3,16776432
0,22.0,Abdominal pain upper,1,16776469
0,22.0,Uterine perforation,6,16776486
0,22.0,Abdominal pain upper,1,16776506
1,22.0,Headache,3,16776506
0,22.0,Fatigue,3,16776508
1,22.0,Peripheral swelling,3,16776508
0,22.1,Abdominal pain upper,3,16776526
1,22.1,Ascites,6,16776526
2,22.1,Decreased appetite,6,16776526
3,22.1,Disease progression,5,16776526
4,22.1,Weight decreased,6,16776526
0,22.0,Gastrointestinal disorder,6,16776529
1,22.0,Autoimmune hepatitis,6,16776529
2,22.0,Nervous system disorder,6,16776529
3,22.0,Myasthenia gravis,6,16776529
0,22.0,Neoplasm progression,6,16776547
0,22.0,Off label use,6,16776549
1,22.0,Death,5,16776549
2,22.0,Intentional product use issue,6,16776549
0,22.1,Arthralgia,2,16776557
1,22.1,Fatigue,2,16776557
2,22.1,Asthenia,2,16776557
3,22.1,Bradycardia,1,16776557
4,22.1,Dizziness,1,16776557
5,22.1,Visual impairment,6,16776557
6,22.1,Neoplasm progression,6,16776557
7,22.1,Blister,2,16776557
8,22.1,Blood pressure increased,1,16776557
9,22.1,Stomatitis,6,16776557
10,22.1,Night sweats,1,16776557
0,22.0,Lung abscess,6,16776562
1,22.0,Pneumonia bacterial,6,16776562
2,22.0,Drug-induced liver injury,2,16776562
3,22.0,Pneumonitis,6,16776562
4,22.0,Tri-iodothyronine free decreased,6,16776562
5,22.0,Blood thyroid stimulating hormone decreased,6,16776562
0,22.0,Colitis,6,16776610
0,22.0,Bone cancer,3,16776636
1,22.0,Weight increased,3,16776636
2,22.0,Muscular weakness,3,16776636
0,22.0,Bone marrow failure,1,16776644
0,22.1,Transitional cell carcinoma,3,16776665
0,22.1,Proteinuria,2,16776676
1,22.1,Renal impairment,1,16776676
2,22.1,Dehydration,1,16776676
3,22.1,Decreased appetite,1,16776676
0,22.0,Alopecia,2,16776712
0,22.0,Metastases to peritoneum,6,16776820
1,22.0,Intestinal perforation,6,16776820
2,22.0,Pneumonia,6,16776820
3,22.0,Gastric cancer,5,16776820
4,22.0,Lymphangiosis carcinomatosa,6,16776820
5,22.0,Malignant ascites,6,16776820
6,22.0,Acute respiratory distress syndrome,6,16776820
0,22.1,Infusion related reaction,,16776825
1,22.1,Chest pain,,16776825
2,22.1,Myalgia,,16776825
0,22.1,Insomnia,,16776834
0,22.0,Acute hepatic failure,5,16776835
0,22.0,Product use in unapproved indication,6,16776837
1,22.0,Breast cancer stage IV,6,16776837
2,22.0,Malignant neoplasm progression,6,16776837
0,22.1,Stomatitis,,16776839
1,22.1,Rash,,16776839
2,22.1,Skin exfoliation,,16776839
3,22.1,Diarrhoea,,16776839
4,22.1,Pain of skin,,16776839
0,22.0,Off label use,,16776844
1,22.0,Gait inability,1,16776844
2,22.0,Asthenia,1,16776844
3,22.0,Diarrhoea,1,16776844
4,22.0,Pyrexia,1,16776844
0,22.0,Duodenal ulcer,6,16776858
0,22.1,Candida infection,6,16776863
1,22.1,Pyrexia,6,16776863
2,22.1,Malignant neoplasm progression,5,16776863
3,22.1,Oesophageal stent stenosis,1,16776863
4,22.1,Pneumonia aspiration,3,16776863
5,22.1,Vascular device infection,3,16776863
6,22.1,Drug-device incompatibility,6,16776863
0,22.1,Disease progression,,16776895
0,22.1,Laboratory test abnormal,2,16776909
1,22.1,Flatulence,3,16776909
2,22.1,Urinary tract infection,2,16776909
3,22.1,Dyspnoea,3,16776909
4,22.1,Oxygen saturation abnormal,6,16776909
5,22.1,Decreased appetite,6,16776909
6,22.1,Dizziness,3,16776909
7,22.1,Condition aggravated,3,16776909
8,22.1,Death,5,16776909
9,22.1,Fatigue,3,16776909
10,22.1,Platelet count decreased,3,16776909
11,22.1,White blood cell count decreased,3,16776909
12,22.1,Micturition urgency,6,16776909
13,22.1,Haematuria,2,16776909
14,22.1,Pollakiuria,6,16776909
0,22.1,White blood cell count decreased,1,16776910
1,22.1,Fatigue,3,16776910
2,22.1,Product dose omission,6,16776910
3,22.1,Nasopharyngitis,6,16776910
4,22.1,Insomnia,3,16776910
5,22.1,Off label use,6,16776910
6,22.1,Bone marrow failure,6,16776910
7,22.1,Product use issue,6,16776910
8,22.1,Nausea,1,16776910
0,22.1,Amnesia,,16776933
1,22.1,Memory impairment,,16776933
2,22.1,Road traffic accident,,16776933
3,22.1,Rib fracture,,16776933
4,22.1,Flushing,,16776933
5,22.1,Fatigue,,16776933
0,22.1,Joint swelling,,16776939
0,22.1,Hair disorder,3,16777002
1,22.1,Alopecia,3,16777002
2,22.1,Hair colour changes,3,16777002
3,22.1,Madarosis,3,16777002
4,22.1,Hair texture abnormal,3,16777002
0,22.0,Septic shock,5,16777007
1,22.0,Congestive cardiomyopathy,5,16777007
2,22.0,Colitis,6,16777007
3,22.0,Bone marrow failure,1,16777007
4,22.0,Steatohepatitis,5,16777007
5,22.0,Diarrhoea haemorrhagic,5,16777007
6,22.0,Pneumonia,5,16777007
7,22.0,Mucosal inflammation,5,16777007
8,22.0,Nausea,5,16777007
9,22.0,Enterocolitis haemorrhagic,5,16777007
10,22.0,Diverticulitis,5,16777007
11,22.0,Atrial fibrillation,5,16777007
12,22.0,Toxicity to various agents,5,16777007
13,22.0,Pancytopenia,5,16777007
14,22.0,Respiratory failure,5,16777007
15,22.0,Cardiotoxicity,5,16777007
16,22.0,Neurotoxicity,5,16777007
17,22.0,Cardiogenic shock,5,16777007
18,22.0,Pericardial effusion,5,16777007
19,22.0,Generalised tonic-clonic seizure,5,16777007
20,22.0,Cardiac failure,5,16777007
21,22.0,Drug ineffective,5,16777007
22,22.0,Stomatitis,6,16777007
0,22.1,Intestinal obstruction,,16777016
0,22.1,Nausea,1,16777055
1,22.1,Cellulitis,1,16777055
2,22.1,Oedema peripheral,1,16777055
3,22.1,Haematocrit decreased,6,16777055
4,22.1,Blood calcium decreased,6,16777055
5,22.1,Lethargy,3,16777055
6,22.1,Vomiting,1,16777055
7,22.1,Erythema,2,16777055
8,22.1,White blood cell count decreased,6,16777055
9,22.1,Oral candidiasis,3,16777055
10,22.1,Decreased appetite,1,16777055
11,22.1,Eosinophil count decreased,6,16777055
12,22.1,White blood cell count increased,6,16777055
13,22.1,Platelet count decreased,6,16777055
14,22.1,Diarrhoea,1,16777055
15,22.1,Dehydration,1,16777055
16,22.1,Constipation,3,16777055
17,22.1,Protein total decreased,6,16777055
18,22.1,Red cell distribution width increased,6,16777055
19,22.1,Pyrexia,1,16777055
20,22.1,C-reactive protein increased,6,16777055
21,22.1,Lymphocyte count decreased,6,16777055
22,22.1,Adjusted calcium decreased,6,16777055
23,22.1,Activated partial thromboplastin time shortened,6,16777055
24,22.1,Activated partial thromboplastin time ratio decreased,6,16777055
25,22.1,Platelet count increased,6,16777055
26,22.1,Red blood cell count decreased,6,16777055
27,22.1,Neutrophil count decreased,6,16777055
28,22.1,Alopecia,3,16777055
29,22.1,Sepsis,1,16777055
30,22.1,Vomiting,1,16777055
31,22.1,Hot flush,3,16777055
32,22.1,Insomnia,3,16777055
33,22.1,Anxiety,3,16777055
0,22.0,Death,5,16777099
0,22.0,Neoplasm progression,5,16777101
0,22.0,Death,5,16777105
0,22.0,Death,5,16777106
0,22.0,Ischaemic stroke,2,16777112
0,22.0,Hepatitis,1,16777129
0,22.1,Death,,16777151
0,22.1,Death,,16777160
0,22.1,Diarrhoea,,16777161
0,22.0,Rash pruritic,3,16777173
1,22.0,Insomnia,6,16777173
2,22.0,Constipation,6,16777173
3,22.0,Nausea,3,16777173
4,22.0,Vomiting,1,16777173
5,22.0,Product dose omission,1,16777173
0,22.1,Hypertension,5,16777175
1,22.1,Chronic kidney disease,1,16777175
2,22.1,Diabetes mellitus,5,16777175
3,22.1,Peripheral vascular disorder,5,16777175
4,22.1,End stage renal disease,5,16777175
0,22.0,Colitis,1,16777177
0,22.0,Cardiac disorder,6,16777182
1,22.0,Intentional product use issue,6,16777182
2,22.0,Off label use,6,16777182
0,22.0,Renal disorder,3,16777185
0,22.0,Bone pain,3,16777207
1,22.0,Fatigue,3,16777207
2,22.0,Hypotension,1,16777207
3,22.0,Nasopharyngitis,1,16777207
4,22.0,Blood pressure increased,1,16777207
5,22.0,Blood glucose increased,6,16777207
6,22.0,Red blood cell count decreased,6,16777207
7,22.0,Glycosylated haemoglobin increased,6,16777207
8,22.0,White blood cell count increased,1,16777207
9,22.0,Adverse drug reaction,6,16777207
10,22.0,Nausea,1,16777207
11,22.0,Pneumonia,6,16777207
12,22.0,Back pain,3,16777207
13,22.0,Myalgia,3,16777207
14,22.0,Blood pressure fluctuation,1,16777207
15,22.0,Tremor,6,16777207
16,22.0,Adverse event,6,16777207
17,22.0,Dyspnoea,2,16777207
18,22.0,Rhinorrhoea,3,16777207
19,22.0,Dyspnoea exertional,6,16777207
20,22.0,Malaise,6,16777207
21,22.0,Pyrexia,1,16777207
22,22.0,Asthenia,2,16777207
23,22.0,Diarrhoea,6,16777207
0,22.0,Metastases to liver,6,16777295
1,22.0,Metastases to skin,6,16777295
2,22.0,Malignant neoplasm progression,3,16777295
3,22.0,Metastases to lymph nodes,6,16777295
4,22.0,Product use in unapproved indication,6,16777295
0,22.1,Hypocalcaemia,1,16777310
1,22.1,Adrenal insufficiency,1,16777310
2,22.1,Hypoglycaemia,1,16777310
0,22.0,Malaise,6,16777323
1,22.0,White blood cell count decreased,6,16777323
2,22.0,Malignant neoplasm progression,6,16777323
3,22.0,Nausea,6,16777323
0,22.1,Nausea,,16777329
1,22.1,Intestinal obstruction,,16777329
0,22.1,Disease progression,,16777351
0,22.1,Disease progression,,16777361
0,22.1,Rash,,16777367
0,22.1,Rectal cancer,6,16777395
0,22.0,Drug tolerance decreased,6,16777417
1,22.0,Toxicity to various agents,6,16777417
0,22.1,Product prescribing error,2,16777420
1,22.1,Hyperkalaemia,2,16777420
2,22.1,Acute kidney injury,2,16777420
3,22.1,Prescribed overdose,2,16777420
4,22.1,Sinus arrest,2,16777420
5,22.1,Rhythm idioventricular,2,16777420
0,22.0,Neutropenia,,16777424
1,22.0,Surgery,,16777424
0,22.0,Toxicity to various agents,6,16777436
0,22.0,Death,5,16777450
0,22.1,Dyspnoea exertional,1,16777455
1,22.1,Malignant pleural effusion,1,16777455
2,22.1,Leukopenia,1,16777455
3,22.1,Neutropenia,1,16777455
4,22.1,Hot flush,3,16777455
5,22.1,Dyspnoea,3,16777455
6,22.1,Pleural effusion,1,16777455
0,22.0,Rhinorrhoea,3,16777535
1,22.0,Abdominal pain,3,16777535
2,22.0,Sneezing,3,16777535
3,22.0,Insomnia,3,16777535
4,22.0,Neoplasm malignant,3,16777535
5,22.0,Thrombosis,3,16777535
6,22.0,Paraesthesia,3,16777535
7,22.0,Hypoaesthesia,3,16777535
0,22.1,Pain in extremity,6,16777548
1,22.1,Peripheral swelling,6,16777548
2,22.1,Gait disturbance,6,16777548
3,22.1,Pruritus,1,16777548
4,22.1,Sleep disorder,6,16777548
0,22.0,Diabetes mellitus,2,16777557
1,22.0,Ketosis,6,16777557
0,22.1,Burning sensation,,16777585
1,22.1,Bladder disorder,,16777585
0,22.1,Drug-induced liver injury,6,16777619
1,22.1,Hepatic enzyme increased,6,16777619
2,22.1,Drug ineffective,6,16777619
0,22.0,Appendicectomy,3,16777633
0,22.0,Diarrhoea,1,16777639
1,22.0,Vomiting,1,16777639
0,22.0,Death,5,16777658
0,22.0,Wound sepsis,5,16777659
1,22.0,Nasopharyngitis,6,16777659
0,22.0,Metastases to bone,6,16777717
1,22.0,Malignant neoplasm progression,6,16777717
2,22.0,Breast cancer,6,16777717
0,22.1,Hypothalamo-pituitary disorder,2,16777720
0,22.0,Dysphonia,3,16777727
1,22.0,Hypertension,3,16777727
2,22.0,Palpitations,1,16777727
0,22.1,Diarrhoea,,16777732
0,22.1,Disease progression,,16777746
0,22.1,Death,,16777757
0,22.1,Colitis ulcerative,,16777792
0,22.0,Fall,2,16777801
1,22.0,Decreased appetite,2,16777801
2,22.0,Joint injury,2,16777801
3,22.0,Insomnia,2,16777801
4,22.0,Psoriasis,3,16777801
5,22.0,Memory impairment,3,16777801
0,22.0,Hyperglycaemia,3,16777802
1,22.0,Nausea,1,16777802
2,22.0,Diarrhoea,1,16777802
3,22.0,Oropharyngeal pain,3,16777802
4,22.0,Rash,1,16777802
5,22.0,Oedema peripheral,2,16777802
6,22.0,Rash,3,16777802
7,22.0,Weight decreased,3,16777802
8,22.0,Anal ulcer,1,16777802
9,22.0,Diarrhoea,1,16777802
10,22.0,Diverticulitis,3,16777802
0,22.1,Hospitalisation,,16777804
0,22.0,Alanine aminotransferase increased,3,16777810
1,22.0,Rash macular,1,16777810
2,22.0,Peripheral swelling,1,16777810
0,22.1,Lower respiratory tract infection,1,16777816
0,22.0,Scleritis,2,16777830
1,22.0,Swelling of eyelid,2,16777830
2,22.0,Visual acuity reduced,2,16777830
3,22.0,Conjunctival hyperaemia,2,16777830
4,22.0,Uveitis,2,16777830
5,22.0,Lymphocyte count decreased,2,16777830
6,22.0,Alpha tumour necrosis factor increased,2,16777830
7,22.0,Influenza like illness,2,16777830
8,22.0,Corneal deposits,2,16777830
9,22.0,Eye oedema,2,16777830
10,22.0,Iris adhesions,2,16777830
11,22.0,Hypopyon,2,16777830
0,22.0,Mucosal inflammation,6,16777870
1,22.0,Malignant neoplasm progression,6,16777870
0,22.1,Drug ineffective,6,16777887
0,22.0,Leukopenia,2,16777893
0,22.1,Febrile neutropenia,1,16777924
0,22.0,Adverse event,1,16777944
1,22.0,Dyspnoea,1,16777944
0,22.0,Arthralgia,6,16778032
1,22.0,Myalgia,6,16778032
2,22.0,Off label use,6,16778032
0,22.0,Death,5,16778033
1,22.0,Off label use,6,16778033
0,22.0,Malignant neoplasm progression,3,16778102
0,22.0,Hair colour changes,3,16778124
0,22.0,Diarrhoea,6,16778189
1,22.0,Drug ineffective,6,16778189
2,22.0,Pulmonary embolism,6,16778189
3,22.0,Lung carcinoma cell type unspecified recurrent,6,16778189
0,22.0,Pneumonia,6,16778195
0,22.1,Cholangitis acute,6,16778207
1,22.1,Hepatitis cholestatic,6,16778207
2,22.1,Acute hepatic failure,1,16778207
3,22.1,Jaundice,1,16778207
4,22.1,Drug-induced liver injury,6,16778207
0,22.0,Pneumonitis,1,16778220
0,22.0,Renal cell carcinoma,3,16778252
1,22.0,Second primary malignancy,3,16778252
0,22.0,Nausea,6,16778318
1,22.0,Thyroid disorder,6,16778318
2,22.0,Diarrhoea,6,16778318
3,22.0,Fatigue,6,16778318
0,22.1,Intentional product use issue,6,16778376
1,22.1,Death,5,16778376
0,22.0,Pleural effusion,5,16778456
1,22.0,Breast cancer metastatic,5,16778456
2,22.0,Malignant neoplasm progression,5,16778456
0,22.0,Cerebral infarction,1,16778480
0,22.1,Back pain,6,16778518
1,22.1,Hypokalaemia,1,16778518
2,22.1,Urinary incontinence,3,16778518
3,22.1,Pneumonia,1,16778518
0,22.1,Dyspnoea,3,16778533
1,22.1,Pulmonary oedema,3,16778533
2,22.1,Malaise,3,16778533
0,22.0,Infection,6,16778565
1,22.0,Pyrexia,2,16778565
0,22.1,Cardiac arrest,5,16778603
1,22.1,Cardiotoxicity,5,16778603
2,22.1,Second primary malignancy,5,16778603
3,22.1,Acute myeloid leukaemia,5,16778603
0,22.0,Vomiting,6,16778604
1,22.0,Diarrhoea,6,16778604
2,22.0,Decreased appetite,6,16778604
3,22.0,Vitamin B1 deficiency,1,16778604
4,22.0,Cognitive disorder,1,16778604
0,22.1,Neonatal asphyxia,5,16778610
1,22.1,Foetal exposure during pregnancy,6,16778610
2,22.1,Foetal death,5,16778610
3,22.1,Stillbirth,5,16778610
0,22.1,Urinary tract infection,6,16778639
1,22.1,Neurotoxicity,6,16778639
2,22.1,Anaemia,6,16778639
3,22.1,Haematology test abnormal,6,16778639
0,22.0,Fatigue,3,16778644
1,22.0,Hypotension,1,16778644
2,22.0,Asthenia,1,16778644
3,22.0,Malaise,1,16778644
0,22.0,Large intestinal obstruction,6,16778703
1,22.0,Diaphragmatic hernia,6,16778703
0,22.0,Osteonecrosis,6,16778704
1,22.0,Uveitis,2,16778704
2,22.0,Influenza like illness,6,16778704
3,22.0,Osteoporosis,6,16778704
0,22.0,Bacteraemia,1,16778723
1,22.0,Pancytopenia,6,16778723
2,22.0,Febrile neutropenia,1,16778723
0,22.0,Feeding disorder,6,16778725
1,22.0,Leukocytosis,6,16778725
2,22.0,Vomiting,6,16778725
0,22.0,Non-small cell lung cancer,6,16778730
1,22.0,Diarrhoea,6,16778730
2,22.0,Neuropathy peripheral,6,16778730
0,22.1,Periarthritis,3,16778748
1,22.1,Herpes zoster,1,16778748
2,22.1,Abdominal pain,1,16778748
3,22.1,Aspartate aminotransferase increased,3,16778748
4,22.1,Hepatic cirrhosis,3,16778748
0,22.0,Pancreatitis,6,16778766
0,22.1,Parosmia,1,16778774
1,22.1,Taste disorder,1,16778774
2,22.1,Flushing,6,16778774
3,22.1,Blood pressure decreased,1,16778774
4,22.1,Dizziness,6,16778774
5,22.1,Abdominal pain,6,16778774
6,22.1,Anaphylactic shock,1,16778774
7,22.1,Abdominal discomfort,6,16778774
0,22.0,Decreased appetite,2,16778781
0,22.1,Alopecia,2,16778796
0,22.0,Ischaemic stroke,2,16778843
0,22.0,Hepatitis acute,2,16778844
0,22.0,Septic shock,1,16778882
1,22.0,Thrombocytopenia,1,16778882
2,22.0,Anaemia,3,16778882
3,22.0,Leukopenia,1,16778882
0,22.0,Blood glucose increased,6,16778901
1,22.0,Therapeutic response unexpected,6,16778901
2,22.0,Diarrhoea,1,16778901
0,22.0,Diarrhoea,2,16778913
1,22.0,Granulocyte count decreased,1,16778913
0,22.0,Emphysema,6,16778930
1,22.0,Hepatic cirrhosis,6,16778930
2,22.0,Cystic lung disease,6,16778930
3,22.0,Pneumonitis,6,16778930
4,22.0,Hepatic cyst,6,16778930
0,22.0,Malignant neoplasm progression,6,16778946
1,22.0,Interstitial lung disease,1,16778946
0,22.1,Application site pruritus,2,16778947
1,22.1,Dandruff,2,16778947
2,22.1,Application site erythema,2,16778947
0,22.0,Oxygen saturation decreased,2,16778954
1,22.0,Chills,2,16778954
2,22.0,Pyrexia,2,16778954
0,22.0,Depression,2,16779013
1,22.0,Intentional overdose,2,16779013
0,22.0,Fatigue,2,16779037
1,22.0,Rash,2,16779037
2,22.0,Oedema,2,16779037
3,22.0,Urticaria,2,16779037
0,22.0,Hepatitis,5,16779045
1,22.0,Polycythaemia vera,6,16779045
0,22.0,Drug resistance,6,16779067
1,22.0,Malignant neoplasm progression,6,16779067
0,22.0,Tremor,6,16779094
1,22.0,Viral sepsis,2,16779094
2,22.0,Influenza,2,16779094
0,22.0,Cardiac dysfunction,6,16779124
0,22.0,Product use in unapproved indication,6,16779163
1,22.0,Myositis,3,16779163
0,22.0,Metastases to peritoneum,6,16779165
1,22.0,Small intestinal obstruction,6,16779165
0,22.0,Ischaemic stroke,2,16779191
0,22.0,Skin ulcer,6,16779229
1,22.0,Blister,6,16779229
0,22.1,Neoplasm progression,6,16779246
1,22.1,Glucose tolerance impaired,6,16779246
0,22.0,Herpes zoster,1,16779265
0,22.0,Drug ineffective,6,16779308
1,22.0,Drug hypersensitivity,6,16779308
0,22.1,Alopecia,3,16779318
1,22.1,Hair colour changes,3,16779318
2,22.1,Hair texture abnormal,3,16779318
3,22.1,Madarosis,3,16779318
4,22.1,Hair disorder,3,16779318
0,22.0,Enterocolitis,6,16779394
0,22.0,Malignant neoplasm progression,6,16779427
1,22.0,Drug resistance,6,16779427
2,22.0,Nausea,6,16779427
3,22.0,Decreased appetite,6,16779427
0,22.0,Decreased appetite,5,16779450
1,22.0,Vomiting,5,16779450
2,22.0,Confusional state,5,16779450
3,22.0,Death,5,16779450
0,22.0,Knee arthroplasty,6,16779492
0,22.0,Pain,6,16779510
1,22.0,Arthralgia,2,16779510
2,22.0,Hot flush,2,16779510
3,22.0,Oedema,2,16779510
4,22.0,Neuropathy peripheral,6,16779510
5,22.0,Musculoskeletal stiffness,2,16779510
6,22.0,Blister,2,16779510
0,22.0,Neuropathy peripheral,6,16779521
0,22.0,Acute myeloid leukaemia,6,16779537
0,22.0,Intestinal perforation,6,16779555
1,22.0,Agranulocytosis,6,16779555
0,22.0,Intestinal perforation,6,16779592
1,22.0,Renal cyst,6,16779592
0,22.0,Febrile neutropenia,5,16779598
0,22.0,Thrombocytopenia,1,16779627
0,22.0,Bone marrow failure,2,16779651
0,22.0,Gastrointestinal toxicity,6,16779702
0,22.0,Toxicity to various agents,6,16779733
1,22.0,Musculoskeletal stiffness,1,16779733
0,22.0,Hepatocellular injury,3,16779736
0,22.0,Paraesthesia,1,16779743
1,22.0,Erythema,1,16779743
2,22.0,Respiratory distress,1,16779743
0,22.0,Cardiac arrest,6,16779750
0,22.0,Drug resistance,6,16779768
1,22.0,Cerebral disorder,6,16779768
2,22.0,Malignant neoplasm progression,6,16779768
0,22.1,Acute kidney injury,5,16779770
1,22.1,Hyperkalaemia,5,16779770
2,22.1,Urinary tract infection staphylococcal,6,16779770
3,22.1,Abdominal distension,5,16779770
4,22.1,Hydronephrosis,6,16779770
5,22.1,Multiple organ dysfunction syndrome,5,16779770
6,22.1,Generalised oedema,5,16779770
7,22.1,Malignant neoplasm progression,5,16779770
0,22.1,Epistaxis,5,16780008
1,22.1,Mouth haemorrhage,5,16780008
2,22.1,Decreased appetite,6,16780008
3,22.1,Haematemesis,6,16780008
4,22.1,Platelet count decreased,6,16780008
0,22.0,Dyspnoea,5,16780042
1,22.0,Fatigue,5,16780042
0,22.0,Haemoglobin decreased,6,16780049
1,22.0,Brain hypoxia,6,16780049
2,22.0,Brain cancer metastatic,3,16780049
3,22.0,Haematuria,6,16780049
0,22.0,Cardiac fibrillation,3,16780073
0,22.0,Malaise,5,16780092
0,22.0,Pleural effusion,2,16780164
0,22.0,Death,5,16780188
0,22.0,Malignant neoplasm progression,6,16780194
1,22.0,Breast cancer metastatic,6,16780194
0,22.1,Product use in unapproved indication,6,16780349
1,22.1,Intestinal obstruction,6,16780349
0,22.0,Hair texture abnormal,3,16780431
1,22.0,Madarosis,3,16780431
2,22.0,Alopecia,3,16780431
3,22.0,Hair colour changes,3,16780431
4,22.0,Hair disorder,3,16780431
0,22.0,Intestinal ischaemia,1,16780441
1,22.0,Gastrointestinal mucosal exfoliation,6,16780441
2,22.0,Toxicity to various agents,1,16780441
3,22.0,Hypoperfusion,1,16780441
4,22.0,Neutropenia,1,16780441
5,22.0,Hypovolaemia,1,16780441
6,22.0,Colitis,1,16780441
7,22.0,Diarrhoea haemorrhagic,1,16780441
8,22.0,Overdose,1,16780441
9,22.0,Bone marrow failure,1,16780441
10,22.0,Stomatitis,1,16780441
0,22.0,Pneumonitis,2,16780462
1,22.0,Pleural effusion,6,16780462
2,22.0,Urticaria,1,16780462
0,22.1,Atrial fibrillation,6,16780467
1,22.1,Pleural effusion,6,16780467
2,22.1,Splenic rupture,6,16780467
3,22.1,Respiratory failure,6,16780467
0,22.0,Drug ineffective,6,16780477
0,22.0,Hepatic function abnormal,6,16780491
1,22.0,Platelet count decreased,6,16780491
0,22.0,Neuropathy peripheral,6,16780503
1,22.0,Conjunctivitis,6,16780503
2,22.0,Neutropenia,6,16780503
3,22.0,Asthenia,6,16780503
4,22.0,Vomiting,6,16780503
5,22.0,Mucosal inflammation,6,16780503
6,22.0,Leukopenia,6,16780503
7,22.0,Alanine aminotransferase abnormal,6,16780503
8,22.0,Aspartate aminotransferase abnormal,6,16780503
9,22.0,Myalgia,6,16780503
10,22.0,Anaemia,6,16780503
11,22.0,Nausea,6,16780503
0,22.0,Diabetes mellitus,2,16780514
0,22.0,Pain in extremity,3,16780519
1,22.0,Fatigue,1,16780519
2,22.0,Diarrhoea,1,16780519
3,22.0,Vitamin D deficiency,1,16780519
4,22.0,Stomatitis,1,16780519
5,22.0,Nasopharyngitis,1,16780519
6,22.0,Pleural effusion,1,16780519
7,22.0,Decreased appetite,1,16780519
0,22.0,Anaphylactic shock,1,16780534
0,22.0,Platelet count decreased,2,16780538
1,22.0,Pain,1,16780538
0,22.0,Death,5,16780540
1,22.0,Lip disorder,6,16780540
2,22.0,Toxic epidermal necrolysis,6,16780540
3,22.0,Chapped lips,6,16780540
4,22.0,Rash,6,16780540
0,22.0,Haematuria,1,16780545
0,22.1,Psychological trauma,6,16780564
1,22.1,Emotional distress,6,16780564
2,22.1,Anxiety,6,16780564
3,22.1,Alopecia,2,16780564
4,22.1,Pain,6,16780564
5,22.1,Impaired quality of life,6,16780564
0,22.1,Anxiety,6,16780579
1,22.1,Impaired quality of life,6,16780579
2,22.1,Alopecia,3,16780579
3,22.1,Pain,6,16780579
4,22.1,Psychological trauma,6,16780579
5,22.1,Emotional distress,6,16780579
0,22.1,Alopecia,2,16780582
0,22.1,Alopecia,2,16780585
0,22.1,Alopecia,2,16780611
1,22.1,Psychological trauma,6,16780611
2,22.1,Emotional distress,6,16780611
0,22.1,Dysarthria,,16780619
1,22.1,Paraesthesia,,16780619
2,22.1,Subdural haematoma,,16780619
0,22.1,Alopecia,2,16780632
1,22.1,Psychological trauma,6,16780632
0,22.1,Impaired quality of life,6,16780636
1,22.1,Psychological trauma,6,16780636
2,22.1,Alopecia,2,16780636
3,22.1,Pain,6,16780636
4,22.1,Emotional distress,6,16780636
5,22.1,Anxiety,6,16780636
0,22.1,Hospice care,,16780637
0,22.1,Pain,6,16780639
1,22.1,Alopecia,2,16780639
2,22.1,Impaired quality of life,6,16780639
3,22.1,Emotional distress,6,16780639
4,22.1,Psychological trauma,6,16780639
5,22.1,Anxiety,6,16780639
0,22.0,Osteoarthritis,1,16780646
0,22.0,Drug resistance,6,16780652
1,22.0,Rash,3,16780652
2,22.0,Malignant neoplasm progression,6,16780652
0,22.0,Product use in unapproved indication,6,16780707
1,22.0,Off label use,6,16780707
2,22.0,Malignant neoplasm progression,6,16780707
0,22.1,Death,,16780728
0,22.1,Injury,6,16780761
1,22.1,Infection,6,16780761
2,22.1,Diarrhoea,6,16780761
3,22.1,Abdominal pain upper,6,16780761
4,22.1,Tooth disorder,6,16780761
5,22.1,Vomiting,1,16780761
6,22.1,Femoral neck fracture,6,16780761
0,22.1,Nausea,1,16780763
0,22.0,Pleural effusion,6,16780779
0,22.1,Pleural effusion,3,16780783
1,22.1,Thyroid cancer,3,16780783
2,22.1,Cardiac failure,5,16780783
0,22.0,Off label use,3,16780788
1,22.0,Off label use,,16780788
2,22.0,Dry skin,3,16780788
3,22.0,Diarrhoea,3,16780788
4,22.0,Fatigue,,16780788
5,22.0,Blister,3,16780788
6,22.0,Interventional procedure,,16780788
0,22.0,Hyperuricaemia,1,16780847
0,22.0,Urinary tract infection,6,16780859
1,22.0,Skin infection,6,16780859
2,22.0,Folliculitis,6,16780859
3,22.0,Pharyngitis,6,16780859
4,22.0,Infection,6,16780859
5,22.0,Oral candidiasis,6,16780859
6,22.0,Herpes virus infection,6,16780859
7,22.0,Nasopharyngitis,6,16780859
8,22.0,Pneumonia,6,16780859
9,22.0,Fungal infection,6,16780859
10,22.0,Lower respiratory tract infection,6,16780859
11,22.0,Herpes zoster,6,16780859
12,22.0,Upper respiratory tract infection,6,16780859
0,22.0,Blood cholesterol increased,6,16780891
0,22.1,Neutrophil count decreased,2,16780924
1,22.1,Febrile neutropenia,2,16780924
0,22.1,Intestinal obstruction,1,16780969
0,22.1,Febrile neutropenia,6,16780985
1,22.1,Paraesthesia,6,16780985
2,22.1,Abdominal discomfort,3,16780985
3,22.1,Photosensitivity reaction,6,16780985
4,22.1,Anaemia,3,16780985
5,22.1,Hot flush,6,16780985
6,22.1,Liver function test increased,6,16780985
7,22.1,Blood urea increased,6,16780985
8,22.1,Infection,3,16780985
9,22.1,Nausea,3,16780985
10,22.1,Neuropathy peripheral,3,16780985
11,22.1,Neutrophil count decreased,2,16780985
12,22.1,Increased appetite,6,16780985
13,22.1,Constipation,1,16780985
14,22.1,White blood cell count decreased,3,16780985
15,22.1,Fatigue,3,16780985
0,22.0,Vomiting,6,16780990
1,22.0,Ulcer haemorrhage,6,16780990
2,22.0,Gastric ulcer,6,16780990
3,22.0,Oesophagitis,6,16780990
4,22.0,Burn oesophageal,6,16780990
5,22.0,Pneumonia,6,16780990
0,22.1,Disease progression,,16781009
0,22.1,Rash,,16781015
0,22.0,Hepatic function abnormal,2,16781038
0,22.0,Vertigo,3,16781061
0,22.1,Psychological trauma,6,16781089
1,22.1,Emotional distress,6,16781089
2,22.1,Alopecia,2,16781089
3,22.1,Impaired quality of life,6,16781089
4,22.1,Anxiety,6,16781089
5,22.1,Pain,6,16781089
0,22.1,Pain,6,16781094
1,22.1,Alopecia,2,16781094
2,22.1,Emotional distress,6,16781094
3,22.1,Anxiety,6,16781094
4,22.1,Impaired quality of life,6,16781094
5,22.1,Psychological trauma,6,16781094
0,22.1,Alopecia,2,16781096
0,22.0,Death,5,16781199
0,22.0,Metastases to bone,2,16781213
1,22.0,Metastases to thorax,2,16781213
2,22.0,Pruritus,2,16781213
3,22.0,Insomnia,3,16781213
4,22.0,Thrombotic stroke,6,16781213
5,22.0,Diplopia,6,16781213
6,22.0,Fatigue,3,16781213
7,22.0,Dry skin,3,16781213
8,22.0,Peripheral swelling,2,16781213
9,22.0,Depressed mood,3,16781213
0,22.0,Osteonecrosis of jaw,1,16781232
1,22.0,Periodontal disease,2,16781232
0,22.0,Pulmonary embolism,5,16781245
1,22.0,Malignant neoplasm progression,5,16781245
2,22.0,Breast cancer metastatic,5,16781245
0,22.0,Decreased appetite,6,16781248
1,22.0,Product use in unapproved indication,6,16781248
0,22.0,Alanine aminotransferase increased,6,16781250
1,22.0,Product use in unapproved indication,6,16781250
0,22.0,Stent placement,6,16781261
1,22.0,Abdominal pain,3,16781261
0,22.0,Polyneuropathy,6,16781271
1,22.0,Drug ineffective,6,16781271
0,22.1,Pain,6,16781279
1,22.1,Alopecia,2,16781279
2,22.1,Anxiety,6,16781279
3,22.1,Impaired quality of life,6,16781279
4,22.1,Psychological trauma,6,16781279
5,22.1,Emotional distress,6,16781279
0,22.0,Colitis,6,16781301
0,22.1,Psychological trauma,6,16781313
1,22.1,Alopecia,2,16781313
0,22.1,Metastases to central nervous system,2,16781368
1,22.1,Hemiparesis,6,16781368
0,22.1,Dehydration,6,16781473
1,22.1,Blood magnesium decreased,6,16781473
2,22.1,Feeling abnormal,6,16781473
3,22.1,Intentional product misuse,6,16781473
4,22.1,Vomiting,3,16781473
5,22.1,Drug intolerance,6,16781473
0,22.1,Asthenia,6,16781487
1,22.1,Diarrhoea,6,16781487
2,22.1,Pain,6,16781487
3,22.1,Constipation,3,16781487
4,22.1,Pleural effusion,6,16781487
5,22.1,Decreased appetite,6,16781487
6,22.1,Haemoglobin decreased,2,16781487
7,22.1,Taste disorder,6,16781487
0,22.0,Headache,6,16781517
1,22.0,Drug reaction with eosinophilia and systemic symptoms,6,16781517
2,22.0,Asthenia,6,16781517
0,22.0,Eczema,6,16781527
1,22.0,Erythema multiforme,6,16781527
2,22.0,Stevens-Johnson syndrome,6,16781527
0,22.1,Thermal burn,3,16781531
1,22.1,Hot flush,6,16781531
2,22.1,Feeling cold,6,16781531
0,22.0,Death,5,16781599
0,22.0,Intentional product use issue,6,16781631
1,22.0,Off label use,6,16781631
2,22.0,Liver injury,1,16781631
0,22.0,Hypopituitarism,3,16781666
1,22.0,Peripheral swelling,3,16781666
2,22.0,Joint swelling,3,16781666
3,22.0,Hyponatraemia,6,16781666
4,22.0,Pituitary enlargement,3,16781666
5,22.0,Headache,1,16781666
6,22.0,Platelet count abnormal,1,16781666
0,22.0,Cardio-respiratory arrest,5,16781682
0,22.0,Death,5,16781685
1,22.0,Malignant neoplasm progression,6,16781685
2,22.0,Drug resistance,6,16781685
0,22.1,Hospice care,,16781699
0,22.0,Abdominal pain upper,6,16781719
1,22.0,Gastritis,1,16781719
2,22.0,Drug intolerance,6,16781719
0,22.0,Diarrhoea,2,16781727
1,22.0,Renal failure,2,16781727
0,22.0,Bone marrow failure,2,16781737
0,22.0,Neoplasm skin,6,16781746
